How can genomic data help predict disease risk and guide cancer treatment?

In the context of translational medicine, genomic data serves as a powerful tool for shifting from a "one-size-fits-all" approach to personalized medicine, where care is tailored to an individual's unique genetic makeup.

Predicting Disease Risk

Genomic data allows health care professionals to practice predictive and preventive medicine by identifying specific genetic variations associated with disease susceptibility. Through genome-wide association studies, researchers identify links between genetic variants and various conditions. For individuals with a family history of hereditary cancers, such as breast cancer or colorectal cancer, genetic testing can detect causative mutations, enabling early screening and lifesaving interventions before symptoms appear.1234

Guiding Cancer Treatment

Genomic data transforms cancer care by enabling targeted therapy, which uses drugs designed to interfere with specific molecular mechanisms driving tumor growth.5
* Molecular Profiling: By sequencing tumor cell genomes, physicians can identify unique genetic "bar codes" or mutations, allowing them to select drugs that specifically target those defects.5
* Companion Diagnostics: Tests are used to predict how a tumor will respond to a specific drug, such as using herceptin for tumors with ERBB2 gene amplification.5
* Monitoring: Molecular techniques like polymerase chain reaction (PCR) help track residual malignant cells, providing an objective measure of treatment success.5